Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
MAPK3 |
mitogen-activated protein kinase 3 |
Mapped by CNV |
|
SHC3 |
SHC (Src homology 2 domain containing) transforming protein 3 |
Mapped by significant region |
TAS[8808684]
|
PLCE1 |
phospholipase C, epsilon 1 |
Mapped by PBA pathway |
NAS[11022048]
|
PRKAR2B |
protein kinase, cAMP-dependent, regulatory, type II, beta |
Mapped by CNV |
|
REPS2 |
RALBP1 associated Eps domain containing 2 |
Mapped by CNV |
TAS[9422736]
|
BAD |
BCL2-associated agonist of cell death |
Mapped by significant region |
|
ITPR2 |
inositol 1,4,5-trisphosphate receptor, type 2 |
Mapped by LD-proxy; Mapped by literature SNP |
|
ITPR1 |
inositol 1,4,5-trisphosphate receptor, type 1 |
Mapped by CNV |
|
NCK2 |
NCK adaptor protein 2 |
Mapped by PBA pathway |
TAS[9737977]
|
RICTOR |
RPTOR independent companion of MTOR, complex 2 |
Mapped by significant region |
|
RPS6KB2 |
ribosomal protein S6 kinase, 70kDa, polypeptide 2 |
Mapped by significant region |
|
ADCY4 |
adenylate cyclase 4 |
Mapped by significant region |
|
UBC |
ubiquitin C |
Mapped by CNV |
|
MAPK1 |
mitogen-activated protein kinase 1 |
Mapped by LD-proxy |
|
UBB |
ubiquitin B |
Mapped by significant region |
|
CBL |
Cas-Br-M (murine) ecotropic retroviral transforming sequence |
Mapped by significant region |
|
BCAR1 |
breast cancer anti-estrogen resistance 1 |
Mapped by significant region |
|
MAPKAP1 |
mitogen-activated protein kinase associated protein 1 |
Mapped by significant region |
|
ADAM17 |
ADAM metallopeptidase domain 17 |
Mapped by significant region |
IDA[12743035]
|
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Mapped by LD-proxy |
NAS[15504738]
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
Mapped by significant region |
|
VIL1 |
villin 1 |
Mapped by significant region |
IDA[17229814]
|